X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Russia roll out the homegrown Sputnik V vaccine for its population

Content Team by Content Team
9th December 2020
in Drug Development, News
Russia roll out the homegrown Sputnik V vaccine for its population

In a first, Russia has started to roll out the homegrown Sputnik V vaccine for its population. This development comes just before the UK’s rollout of Pfizer vaccine, which is slated for this week. Sputnik V has been made available in Moscow starting Saturday. Initially, it shall be administered to doctors, teachers and social workers. Russia is the fourth worst-hit country from this deadly virus and there is no respite from it as the numbers continue to rise. The Russian officials are planning for a nationwide vaccination campaign starting next week. That said, it will be a limited scale roll out as the manufacturers have encountered challenges in ramping up production.

There has been a significant decrease in the estimated number of doses from the previously thought of strategy. Russia is now expecting to produce between 2 million and 10 million doses by this year-end as against the erstwhile 30 million doses which were planned during the vaccine’s launch in August. Russia was the first country to approve COVID-19 vaccine amidst the apprehension raised by many upon the speed with which it was developed. The country even faced criticism for not having large scale clinical trial data to support the vaccine’s efficacy.

Moscow has opened doors to 70 vaccination centres in Hospitals and Clinics from Saturday morning. People have started receiving text messages on their eligibility of getting vaccinated and have therefore enrolled online to get the shot. Looks like Kremlin is leaving no loose ends to make Sputnik V a success as it has not introduced any second lockdown despite the growing number of COVID cases.

It needs to be added that the jab is free of cost for the Russian citizens.  In Moscow alone, from a population of 12 million, around 5000 signed up for the first shot on Friday. The entire procedure for vaccination would take around an hour wherein there would be a pre and post-shot doctor examination as well as an observation window of 30 minutes. Those vaccinated will then receive a text message after three weeks for their next shot.  With all that there is, vaccine scepticism is still pounding. Officials have said that around 70% of the population needs to be vaccinated to halt the spread, but as per a recent poll conducted by Levada centre, only 36% would get injected.

Although there has been a decline in the expected dosage manufacturing numbers, President Putin says that he sees this as an opportunity to start if not mass, a large scale vaccination. Russia has 11 time zones and all are gearing up for a vaccine roll out next week. Authorities in St. Petersburg have started buying freezers that can maintain ultra-low temperatures, which is a primary requirement to store the jab.

Previous Post

From “Approved” to “Available” – Innovations in Scaling Parenteral Drug Manufacturing

Next Post

The UK begins the biggest ever immunization program

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
The UK begins the biggest ever immunization program

The UK begins the biggest ever immunization program

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In